ArticleCureus2025
Evaluation of Thyroid Dysfunction in Type 2 Diabetes Mellitus Patients and Its Association With Diabetic Complications: A Cross-Sectional Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Combined Treatment of Type 2 Diabetes and Hypothyroidism: Impact of Oral Semaglutide and Levothyroxine on Cardiometabolic and Thyroid Parameters: A 6-Month Comparative Study.Epidemiologia (Basel, Switzerland) · 2026Article
- Analysis of Anxiety and Depression Status and Risk Factors in Postmenopausal Women With Diabetes Mellitus Complicated by Hypothyroidism.Actas espanolas de psiquiatria · 2026Article
- The role of clinical laboratory parameters in diabetic neuropathy: correlations and recent advances.Frontiers in endocrinology · 2026Review
- Association Between Thyroid Hormone Sensitivity and Peripheral Arterial Disease in Euthyroid Patients with Type 2 Diabetes.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Type 2 diabetes mellitus (T2DM) is a widespread metabolic disorder that contributes significantly to morbidity and mortality due to its associated complications. Among these, thyroid dysfunction is one of the most common and may play a role in the progression of diabetic complications. This study explores the relationship between thyroid dysfunction and both microvascular and macrovascular complications in individuals with T2DM. Methods This cross-sectional observational study was conducted among 200 patients with T2DM, aged 30-70 years, at the Department of General Medicine, Gujarat Medical Education and Research Society (GMERS) Medical College and Hospital, Valsad, India. Participants were screened for thyroid dysfunction and diabetic complications, including retinopathy, nephropathy, neuropathy, and peripheral arterial disease (PAD). Blood tests were performed to measure thyroid hormone levels (thyroid-stimulating hormone, free triiodothyronine, and free thyroxine) and diabetes-related parameters such as glycated hemoglobin (HbA1c). Data were analyzed using chi-square tests and multivariate regression analysis to evaluate the correlation between thyroid dysfunction and the development of diabetic complications. Results The prevalence of thyroid dysfunction in the study population was 26.5%, with hypothyroidism being more common (84.9%) than hyperthyroidism (15.1%). Diabetic complications were significantly more prevalent among individuals with hypothyroidism compared to those with normal thyroid function. Hypothyroidism was independently associated with increased odds of diabetic retinopathy (OR = 7.72), diabetic nephropathy (OR = 4.87), neuropathy (OR = 3.10), and PAD (OR = 8.12). In contrast, hyperthyroidism showed no significant association with diabetic complications. Conclusions Hypothyroidism in individuals with T2DM is significantly associated with a higher risk of both microvascular and macrovascular complications. These findings highlight the importance of incorporating thyroid function assessment into routine diabetic care, as optimizing thyroid hormone levels may help mitigate the risk of these complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.